HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/5/C1173    most recent 00528.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Cuppoletti, J. Articles by Ueno, R. Search for Related Content PubMed PubMed Citation Articles by Cuppoletti, J. Articles by Ueno, R.

TRANSLATIONAL PHYSIOLOGY

SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents

¹Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio 45267-0576; and ²Sucampo Pharmaceuticals, Inc., Bethesda, Maryland 20814

Submitted 26 November 2003 ; accepted in final form 21 June 2004

ABSTRACT

The purpose of this study was to determine the mechanism of action of SPI-0211 (lubiprostone), a novel bicyclic fatty acid in development for the treatment of bowel dysfunction. Adult rabbit intestine was shown to contain mRNA for ClC-2 using RT-PCR, Northern blot analysis, and in situ hybridization. T84 cells grown to confluence on permeable supports were shown to express ClC-2 channel protein in the apical membrane. SPI-0211 increased electrogenic Cl^– transport across the apical membrane of T84 cells, with an EC₅₀ of 18 nM measured by short-circuit current (I_sc) after permeabilization of the basolateral membrane with nystatin. SPI-0211 effects on Cl^– currents were also measured by whole cell patch clamp using the human embryonic kidney (HEK)-293 cell line stably transfected with either recombinant human ClC-2 or recombinant human cystic fibrosis transmembrane regulator (CFTR). In these studies, SPI-0211 activated ClC-2 Cl^– currents in a concentration-dependent manner, with an EC₅₀ of 17 nM, and had no effect in nontransfected HEK-293 cells. In contrast, SPI-0211 had no effect on CFTR Cl^– channel currents measured in CFTR-transfected HEK-293 cells. Activation of ClC-2 by SPI-0211 was independent of PKA. Together, these studies demonstrate that SPI-0211 is a potent activator of ClC-2 Cl^– channels and suggest a physiologically relevant role for ClC-2 Cl^– channels in intestinal Cl^– transport after SPI-0211 administration.

cystic fibrosis transmembrane regulator; intestinal chloride channels; chloride channel opener

This article has been cited by other articles:

				H. F. Bao, L. Liu, J. Self, B. J. Duke, R. Ueno, and D. C. Eaton A synthetic prostone activates apical chloride channels in A6 epithelial cells Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G234 - G251. [Abstract] [Full Text] [PDF]

				E. M Ambizas and R. Ginzburg Lubiprostone: A Chloride Channel Activator for Treatment of Chronic Constipation Ann. Pharmacother., June 1, 2007; 41(6): 957 - 964. [Abstract] [Full Text] [PDF]

				A. J. Moeser, P. K. Nighot, K. J. Engelke, R. Ueno, and A. T. Blikslager Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G647 - G656. [Abstract] [Full Text] [PDF]

				Lubiprostone (amitiza) for chronic constipation. Obstet. Gynecol., October 1, 2006; 108(4): 1026 - 1027. [Full Text] [PDF]

				M. Camilleri, A. E. Bharucha, R. Ueno, D. Burton, G. M. Thomforde, K. Baxter, S. McKinzie, and A. R. Zinsmeister Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G942 - G947. [Abstract] [Full Text] [PDF]